PCR111 Real-World Evidence on Adherence to the First CDK 4/6 Inhibitor (Palbociclib) in Breast Cancer Patients From Romania
Abstract
Authors
A. Turcu-Stiolica M.S. Naidin V Gheorman M Aldea EA Dumitrescu SR Volovat D.M. Median CV Lungulescu